Skip to content

Waystar Holding Corp. WAY Total costs & expenses

Total costs & expenses at other companies

Oracle logo
OracleORCL
$13.05B+20.9%
Astrana Health logo
Astrana HealthASTH
$936.57M+56.1%
UnitedHealth Group logo
UnitedHealth GroupUNH
Flywire Corporation logo
Flywire CorporationFLYW

Other financials

Income statement

See full
Revenue$313.9M+22.4%
Gross profit$216.8M+25.3%
Operating income$80.5M+23.4%
Net income$43.3M+47.9%
EPS (diluted)$0.22+37.5%

Balance sheet

See full
Cash & equivalents$62.7M-74.9%
Total debt$1.5B+18.0%
Total equity$3.9B+26.0%
Total assets$5.8B+26.4%

Cash flow

See full
Operating cash flow$84.9M+32.2%
CapEx$15.3M+182%
Free cash flow$69.6M+18.3%

Valuation

See full
Market cap$3.53B-28.1%

Profitability

See full
Gross margin68.7%+1.9pp
Operating margin22.9%+7.1pp
Net margin10.9%
FCF margin25.4%+5.3pp

Returns & leverage

See full
Return on equity3.6%
Debt / equity0.4×0.0×
Current ratio1.8×-1.4×

Where this comes from

Reported directly by Waystar Holding Corp. in its filing.

Tagged under the XBRL concept us-gaap:CostsAndExpenses.

The official record: Waystar Holding Corp.’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about Waystar Holding Corp.'s total costs & expenses.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Waystar Holding Corp.'s total costs & expenses?
Waystar Holding Corp. (WAY) reported total costs & expenses of $233.41M in Q1 2026.
How has Waystar Holding Corp.'s total costs & expenses changed year-over-year?
Waystar Holding Corp.'s total costs & expenses increased by 22.1% year-over-year, from $191.23M to $233.41M.
What is the long-term trend for Waystar Holding Corp.'s total costs & expenses?
Over 3 years (2022 to 2025), Waystar Holding Corp.'s total costs & expenses has grown at a 11.4% compound annual growth rate (CAGR), from $615.42M to $849.97M.
What does total costs & expenses mean?
This metric represents the aggregate sum of all operating and non-operating costs incurred by the company to generate revenue during a specific reporting period. It encompasses the direct costs of revenue, research and development, sales and marketing, and general administrative expenses, as well as depreciation and amortization. Monitoring this figure allows investors to assess the company's overall cost structure and operational efficiency in relation to its top-line performance.